Dermatomyositis and nasopharyngeal carcinoma

Journal of Dermatology

Volumn 25, Issue 8, 1998, Pages 539-543

  Abraham, Zeev ^a   Rosner, Itzhak ^b   Rozenbaum, Michael ^b   Goldenberg, Katalin ^b   Weller, Boaz ^b  

^a Reish Policlinic ^*  (Israel)

^b BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

Computed tomography scan; Dermatomyositis; Nasopharyngeal carcinoma; Risk factors

Indexed keywords

ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; CREATINE KINASE; IMMUNOGLOBULIN; METHOTREXATE; PREDNISONE; RHEUMATOID FACTOR;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DERMATOMYOSITIS; DISEASE ASSOCIATION; ELECTROMYOGRAM; HUMAN; JEW; MALE; MUSCLE BIOPSY; NASOPHARYNX CARCINOMA; RISK FACTOR;

EID: 0031695487     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1998.tb02451.x     Document Type: Article

References (34)

1. Peng JC, Sheen TS, Hsu MH: Nasopharyngeal carcinoma with dermatomyositis, Arch Otolaryngol Head Neck Surg, 121: 1298-1301, 1995.
2. Richardson JB, Callen JP: Dermatomyositis and malignancy, Med Clin North Am, 73: 1211-1220, 1989.
3. Arundell FD, Wilkinson RD, Haserick JR: DM and malignant neoplasm in adults, Arch Dermatol, 82: 772-775, 1960.
4. Manchul LA, Jin A, Pritchard KI, Tenenbaum J, Boyd NF, Leep P: The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis. A control study, Arch Intern Med, 145: 1835-1839, 1985.
5. Barnes BE: DM and malignancy: A review of the literature, Ann Intern Med, 84: 68-76, 1976.
6. Callen JP, Chanda JJ, Stawiski MA: Dermatomyositis and malignancy, Ann Intern Med, 84: 751-752, 1976.
7. Scaling ST, Kaufman RH, Pattera BM: Dermatomyositis and female malignancy, Obstet Gynecol, 54: 474-477, 1979.
8. Callen JP, Hyla JF, Boles GG, Kay DR: The relationship of dermatomyositis and polymyositis to internal malignancy, Arch Dermatol, 116: 295-298, 1980.
9. Vesterager L, Worm AM, Thomsen K: Dermatomyositis and malignancy, Clin Exp Dermatol, 5: 31-35, 1980.
10. Callen JP: Dermatomyositis and polymyositis, in Callen JP (ed): Cutaneous Aspects of Internal Disease, Year Book Publ, Chicago, 1981, pp 21-35.
11. Callen JP: The value of malignancy evaluation in patients with dermatomyositis, J Am Acad Dermatol, 6: 253-258, 1982.
12. Chan HL: Dermatomyositis and cancer in Singapore, Int J Dermatol, 24: 447-450, 1985.
13. Hidano A, Kaneko A, Arai Y, Kikuchi R: Survey of the prognosis of DM with special reference to its association with malignancy and pulmonary fibrosis, J Dermatol (Tokyo), 13: 233-241, 1986.
14. Lakhapnal S, Bunch TW, Ilstrup DM, Melton LJ: Polymyositis-dermatomyositis and malignant lesions, Does an association exist?, Mayo Clin Proc, 61: 645-653, 1986.
15. Plotz PH, Dalakas M, Left RL, Lovel LA, Miller FW, Cronin ME: Current concepts in the idopathic inflammatory myophaties: Polymyositis, dermatomyositis and related disorders, Ann Intern Med, 111: 143-157, 1989.
16. Callen JP: Malignancy in polymyositis/dermatomyositis, Clin Dermatol, 6: 55-63, 1988.
17. Ko HS, Ogryzlo MA, Pruzanski W: Polymyositis in a patient with multiple neoplasms, J Rheumatol, 3: 233-240, 1976.
18. Bonnetblanc JM, Bernard P, Fayol J: Dermatomyositis and malignancy: A multicenter cooperative study, Dermatologica, 180: 212-216, 1990.
19. Dalakas MC: Polymyositis, dermatomyositis, and inclusion-body myositis, New Engl J Med, 325: 1487-1498, 1991.
20. Sigurgeirsson B, Lindelöf B, Edhag O, Allander E: Risk of cancer in patients with dermatomyositis or polymiositis. A population-based study, New Engl J Med, 326: 363-367, 1992.
21. Berkow R, Talbott JM: Musculoskeletal and connective tissue disorders, in Berkow R (ed): The Merck Manual, 13th ed, Merck Sharp & Dome Research Lab, Rahway, 1977, pp 1312-1381.
22. Choa G: Nasopharyngeal carcinoma, J Laryng and Otology, 88: 145-158, 1974.
23. Mahjoubi R, Bachouchi M, Munck JN, et al: Phase II trial of recombinant Interferon gamma in refractory undifferentiated carcinoma of the nasopharynx, Head & Neck, 15: 115-118, 1993.
24. Ballenger JJ: The nasopharynx, in Ballenger JJ (ed): Diseases of the Nose, Throat, Ear and Neck, 14th ed, Lea & Febiger, Philadelphia, 1991, pp 294-298.
25. Pearson CM, Bohan A: The spectrum of polymyositis and dermatomyositis, Med Clin North Am, 61: 439-457, 1977.
26. Steigerwald JC: Polymyositis-dermatomyositis - The inflammatory myopathies, in Samter M, Talmage DW, Frank MM, Austen KF, Calman NH (eds): Immunological Diseases, 4th ed, Little Brown and Co, Boston, 1988. pp 1437-1457.
27. Rowell NR: Dermatomyositis, in Rook A, Wilkinson GS, Ebling FJG (eds): Texbook in Dermatology, 3rd ed, Blackwell, Oxford, 1979, pp 1236-1245.
28. Sela O, Shoenfeld Y: Cancer in autoimmune disease, Seminars in Arthritis and Rheumatism, 18: 77-87, 1988.
29. Wong KO: Dermatomyositis: A clinical investigation of 23 cases in Hong Kong, Br J Dermatol, 81: 544-547, 1969.
30. Chan HL: Dermatomyositis and cancer in Syngapore, Int J Dermat, 24: 447-450, 1985.
31. Norman EL, Kaplan M, Treiger M: Dermatomyositis with squamous cell carcinoma of the nasypharynx, Arch Derm, 106: 410, 1972.
32. Teo P, Tai TH, Choy D: Nasopharyngeal carcinoma with dermatomyositis, Int J Radiation Onrol, 16: 471-474, 1989.
33. Tong M: A review of dermatomyositis cases at the hospital Beson Kuala Lumpur 1989-1993, Med J Malaysia, 50: 32-36, 1995.
34. Macdonald MR, Freeman JL, Hui MF, et al: Role of Epstein-Barr virus in fine-needle aspirates of metastatic neck nodes in the diagnosis of nasopharyngeal carcinoma. Head & Neck, 17: 487-493, 1995.